Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3KP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,226
Award facts
- Contract value 100% obligated
- $39,226.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $39,226.16 on January 15, 2026, by the Defense Logistics Agency for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price, non-set-aside delivery order is expected to be completed by January 16, 2026, with performance occurring at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs for military and defense-related healthcare systems.
This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving military treatment facilities, the Defense Health Agency, and other federal healthcare systems. AmerisourceBergen's performance under this and similar contracts demonstrates its significant role as a primary pharmaceutical distributor for federal medical procurement.
Quick answers
Who was awarded contract SPE2DR26FG3KP?
SPE2DR26FG3KP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FG3KP worth?
The government has obligated $39,226 on SPE2DR26FG3KP.
Is contract SPE2DR26FG3KP an order under another contract?
Yes. SPE2DR26FG3KP is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3KP competed?
The extent of competition for SPE2DR26FG3KP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award